Skip Navigation
 
 
 
 xxx
 
Print This Page
Share this page: More
 

Prevention, Diagnosis, and Treatment

Image of smiling man, Jerry Morton, with black Baltimore Ravens football t-shirt.
Jerry Morton, retired
firefighter, is battling his
lung cancer with an
epigenetic therapy as part
of Johns Hopkins-based
research and an ongoing
clinical trial. 

More than 226,000 people will be diagnosed with lung cancer in the United States each year. Slightly more than 160,000 people will die, more than from colon, breast, and prostate cancers combined.

These sobering statistics motivate the team devoted to lung cancer at Johns Hopkins in their efforts to offer those at risk for lung cancer tools and knowledge to prevent the disease and to offer those patients diagnosed with lung cancer expert treatment and groundbreaking clinical trials.

A multidisciplinary approach

Because lung cancer requires a multi-modality (more than one treatment) approach, the lung cancer team at Johns Hopkins operates as a multidisciplinary unit that includes medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, nurse practitioners, and others. These specialists participate in Johns Hopkins’ multidisciplinary clinic, which offers patients and their families the opportunity to meet with the specialists to discuss the diagnosis and create a treatment plan.

Groundbreaking research

For every member of the team, the goal is to offer patients the best prognosis possible. That’s why practitioners at Johns Hopkins often doresearch as well. Researchers can offer the latest experimental treatments to patients. Working across disciplines opens up new possibilities for better ways to treat lung cancer. Lung cancer patients at Johns Hopkins receive not only experienced, specialized care but also benefit from the pioneering lung cancer research that has resulted in new treatments and therapies.

With the pioneering research in epigenetics, signal transduction, immunotherapy, and biomarkers taking place at Johns Hopkins, the promise of longer life is closer than ever to becoming a reality.

Find out more

For an appointment and answers to your questions

As a leading treatment center for lung cancer, Johns Hopkins offers its patients personalized care, specialized treatment, and pioneering therapies to extend life.

To make an appointment or if you have questions, call 410-955-LUNG (5864).

 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-LUNG (5864)
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer